Lithium Beyond Bipolar: A New Role in Brain Health

 In recent years, psychiatry has undergone a paradigm shift: Researchers are increasingly examining how metabolism, inflammation, micronutrients, and mitochondrial function influence brain health and resilience.

One compound drawing renewed attention in this context is lithium. Long recognized as a cornerstone treatment for bipolar disorder at pharmacologic doses, lithium is now being reconsidered as a trace element with broader physiologic roles in neuroprotection, neuroplasticity, and systemic regulation.

This evolving perspective was accelerated by a landmark study published in Nature last August. Aron and colleagues demonstrated that lithium is present in the human brain at trace concentrations and proposed that insufficient lithium in the brain may contribute to neuronal vulnerability and cognitive decline. These findings suggest that lithium may function not only as a therapeutic agent at higher doses but also as a biologically relevant micronutrient involved in maintaining neural stability.

At the same time, interest in lithium has expanded within functional and integrative psychiatry. Some clinicians are exploring low-dose lithium compounds, including lithium orotate, as potential tools to support mood regulation, cognitive resilience, and neuroprotection. Controlled clinical trials evaluating these approaches, however, remain limited.

Taken together, emerging research from neuroscience, nutritional psychiatry, and metabolic medicine suggests that lithium may play a broader and more foundational role in brain biology than previously appreciated. As the field continues to evolve, understanding lithium’s physiologic functions may help reshape how clinicians think about resilience, neurodegeneration, and the biological foundations of mental health.

Nature: Lithium Deficiency and Alzheimer’s 

The Nature study constitutes a major development in lithium research, as the researchers examined the relationship between lithium availability and neurodegenerative disease.

Liviu Aron, PhD, from Harvard Medical School, and colleagues demonstrated that lithium is naturally present in the human brain and that individuals with mild cognitive impairment and Alzheimer’s disease exhibit significantly lower concentrations of lithium in brain tissue compared with healthy controls.

Intriguingly, the study also found that amyloid plaques — the protein aggregates characteristic of Alzheimer’s pathology — appear to sequester lithium, functioning as molecular “sponges” that trap the mineral and potentially deprive surrounding neurons of its biological effects.

Experimental findings suggested that lithium depletion in neural systems was associated with:

• Accelerated memory decline
• Increased neuroinflammation
• Synaptic disruption
• Widespread neuronal vulnerability

When lithium was restored at trace nutritional doses, researchers observed notable improvements in experimental models. Memory performance stabilized, inflammatory signaling decreased, and structural integrity of neuronal and glial networks — including neurons, astrocytes, and oligodendrocytes — was preserved.

These findings raise an important systems-level question: Lithium depletion may not simply be a consequence of neurodegeneration but could represent a previously underrecognized contributor to neuronal vulnerability.

From a functional medicine perspective, this reframes lithium insufficiency as a potentially modifiable risk factor in cognitive aging.

Natural Element 

Lithium is the third element on the periodic table and occurs naturally throughout the Earth’s crust. It is present in trace amounts in groundwater, soil, plant foods, and mineral springs. Historically, lithium-rich waters were associated with calming and mood-stabilizing effects, long before the development of modern psychopharmacology.

The name “lithium” derives from the Greek word lithos, meaning stone — reflecting its natural geological origins.

Small quantities of lithium are detectable in foods such as:

• Leafy greens
• Legumes
• Grains
• Root vegetables

While concentrations are extremely small, ecologic research suggests they may carry biological significance.

A meta-analysis published in the British Journal of Psychiatry found that regions with higher naturally occurring lithium concentrations in drinking water tend to exhibit significantly lower suicide rates. Although ecologic studies cannot establish causality, the consistency of these associations across multiple geographic regions suggests that environmental lithium exposure may influence population-level mental health outcomes.

These observations have contributed to growing scientific interest in lithium as a trace mineral with neuromodulatory benefits.

Mechanisms of Low-Dose Lithium

Lithium’s biological effects extend far beyond a single neurotransmitter pathway. It influences a broad network of cellular processes that intersect with modern models of metabolic and inflammatory psychiatry.

Mitochondrial support. Mitochondria play a central role in neuronal energy production and cellular resilience. Dysfunction in mitochondrial metabolism has been increasingly implicated in depression, bipolar disorder, neurodegeneration, and cognitive decline.

Experimental research indicates that lithium may enhance mitochondrial efficiency, improve ATP production, and reduce oxidative burden within neurons. By supporting cellular energy metabolism, lithium may contribute to improved neural stability and stress resilience.

Anti-inflammatory modulation. Chronic low-grade inflammation is increasingly recognized as a shared biological driver across numerous psychiatric and neurologic conditions.

Lithium has been shown to modulate inflammatory signaling pathways and reduce overactivation of microglial cells, the immune cells of the central nervous system. Dysregulated microglial activity contributes to neuroinflammation implicated in disorders ranging from depression to Alzheimer’s disease. 

Through these mechanisms, lithium may help dampen inflammatory cascades that disrupt neural circuitry.

Oxidative stress regulation. Oxidative stress occurs when reactive oxygen species accumulate faster than antioxidant defenses can neutralize them. This imbalance contributes to neuronal damage, aging, and psychiatric vulnerability.

Lithium has demonstrated antioxidant effects in experimental systems, reducing oxidative damage and supporting neuronal survival under chronic stress conditions.

Neurotransmitter stabilization. Lithium influences multiple neurotransmitter systems involved in emotional regulation. Research suggests that lithium can modulate serotonin signaling, enhance inhibitory GABAergic (gamma-aminobutyric acid) activity, and regulate dopamine and glutamate dynamics.

Rather than acting as a sedative, low-dose lithium appears to buffer excessive neural excitability, promoting emotional stability and cognitive clarity.

Neurotrophic and synaptic effects. Lithium has also been shown to increase expression of brain-derived neurotrophic factor (BDNF), a key molecule involved in neuronal survival, synaptic plasticity, and learning. Increased neurotrophic signaling supports the formation and maintenance of healthy neural networks.

Inflammation, Metabolism, Mental Health 

Modern psychiatric research increasingly recognizes that mental illness often reflects systemic biological dysregulation. 

Chronic inflammation contributes to:

• Synaptic dysfunction
• Abnormal neural pruning
• Amyloid and tau pathology
• Insulin resistance
• Vascular impairment

Simultaneously, mitochondrial dysfunction reduces neuronal energy production while promoting oxidative and metabolic stress.

Lithium appears to act at this intersection of metabolism, inflammation, and neuroplasticity, helping regulate inflammatory cascades while supporting mitochondrial function. These overlapping effects align closely with the principles of functional and metabolic psychiatry. 

Cognitive support and neuroprotection. Patients with family histories of neurodegenerative disease or early cognitive concerns may benefit from broader neuroprotective strategies that include nutrition, metabolic health optimization, sleep regulation, and physical activity. Trace lithium may be considered as one component of these comprehensive approaches.

Mood instability and impulsivity. In individuals experiencing mood lability, irritability, or impulsivity, low-dose lithium may help stabilize neural signaling without requiring the serum monitoring associated with pharmacologic lithium therapy.

Supporting antidepressant tapering. Discontinuation of antidepressants can be accompanied by neurochemical fluctuations, inflammatory rebound, and mitochondrial stress.

Functional psychiatry approaches to tapering may include:

• Mitochondrial nutrients such as CoQ10 or acetyl-L-carnitine
• Magnesium and B-vitamin repletion
• Anti-inflammatory nutrition
• Trace mineral support

Lithium’s potential to stabilize neurotransmitter systems and buffer excitotoxic signaling may provide supportive regulation during carefully supervised taper protocols.

Neuroimmune Regulation 

Emerging research continues to highlight the importance of vitamin D in brain and immune function. Vitamin D influences inflammatory cytokine signaling, mitochondrial gene expression, and neurotrophic pathways involved in mood regulation. These biological pathways overlap substantially with lithium’s mechanistic profile.

Both lithium and vitamin D influence:

• Neuroinflammatory signaling
• Mitochondrial resilience
• Neuroplasticity pathways

Within nutritional psychiatry frameworks, optimizing vitamin D status alongside trace mineral sufficiency represents a practical strategy for supporting neuroimmune balance and mental health resilience.

Metabolic Psychiatry: A Broader Framework 

The emerging field of metabolic psychiatry proposes that mood and cognition are deeply intertwined with cellular energy metabolism, insulin sensitivity, circadian rhythm integrity, and inflammatory balance.

Within this framework, low-dose lithium aligns with several key biological targets:

• Mitochondrial ATP production
• Neuroinflammatory modulation
• Synaptic stability
• Metabolic signaling pathways

Lifestyle interventions remain foundational. Nutrient-dense foods, physical activity, exposure to nature, circadian rhythm balance, restorative sleep, and stress-modulating practices (eg, yoga, tai chi) support the biological systems that maintain psychiatric stability.

Lithium complements these interventions by supporting the cellular infrastructure upon which mental health depends.

Lithium in Psychiatric Practice 

Lithium’s scientific identity is evolving. Once viewed primarily as a high-dose mood stabilizer used in severe psychiatric illness, lithium is increasingly being examined within a broader biological context. At trace nutritional levels, lithium functions as an integral resilience-supporting micronutrient influencing inflammation, metabolism, and neuroplasticity.

The findings reported in the 2025 Nature study provide a compelling biological rationale for continued investigation: If lithium depletion contributes to neurodegenerative vulnerability, restoring physiologic levels may represent a preventive strategy rather than a purely therapeutic intervention.

It is encouraging to see research continuing to evolve in support of lithium’s potential to confer benefits across multiple dose ranges and formulations. A recent pilot randomized clinical trial in JAMA Neurology in individuals with mild cognitive impairment found that low-dose lithium was associated with slower decline in verbal memory, with signals of greater benefit in amyloid-positive individuals — findings that are directionally consistent with lithium’s effects on neuroinflammation, synaptic integrity, and GSK-3 beta signaling.

It is important to note that this study utilized lithium carbonate, whereas lithium orotate — more commonly used in integrative practice — may differ in brain transport and intracellular retention, with implications for greater neural bioavailability and downstream neuroprotective effects. From a functional and metabolic perspective, these distinctions are meaningful: Form, dose, and individual biology are likely to shape clinical response. The modest effects observed with carbonate may therefore reflect pharmacokinetic constraints rather than limitations of lithium’s underlying mechanisms.

Taken together with emerging evidence linking lithium homeostasis to neurodegenerative vulnerability — including the 2025 Nature findings — lithium can be more fully understood not simply as a pharmacologic agent, but as a biologically relevant regulator of the neuroimmune and metabolic systems that underpin cognitive stability and long-term brain resilience.

James M. Greenblatt, MD, is a dual board-certified psychiatrist and internationally recognized leader in functional and integrative psychiatry. He has spent more than 30 years advancing precision-based approaches to mental health and is the founder of Psychiatry Redefined, an educational platform for clinicians worldwide.

https://www.medscape.com/viewarticle/lithium-beyond-bipolar-new-role-brain-health-2026a10009nk